Introduction: The Need for Streamlined Evaluation of Cellular and Gene Therapies Under many traditional clinical trial conditions, a single investigational product requires an individual Investigational
We will explain the ways in which Center for Biologics Evaluation and Research (CBER) has regulatory authority over these novel therapies via the Public Health
Corrective and preventive action (CAPA) is one of the most critical elements of Title 21 CFR Part 820, because it creates a foundation for continuous
Does innovation and regulation coexist peacefully or are they simply two sides of the corporate coin destined to battle forever? Amidst the dynamic and
Let us guide you through the key foundations of regulatory excellence and quality assurance built for success. Seamless regulatory compliance and superior quality is non-negotiable
As part of this wide umbrella of regulations, Subpart I specifically addresses laboratory controls due to their importance in ensuring the quality of products and
It is important to maintain the highest standards and comply with stringent regulations to guarantee drug safety and performance. Among them, Title 21, Chapter I
The pharmaceutical industry is formally regulated to ensure the safety, efficacy, and quality of the relevant drugs on a national and international level. For instance,
The Code of Federal Regulations (CFR) 21 PART 211 Subpart C [211.42 – 211.162] lays out the regulations for buildings and facilities used in the